Literature DB >> 33479327

Positive lymph node ratio is an index in predicting prognosis for remnant gastric cancer with insufficient retrieved lymph node in R0 resection.

Honghu Wang1, Hao Qi1, Xiaofang Liu1, Ziming Gao1, Iko Hidasa1, Ailixier Aikebaier1, Kai Li2.   

Abstract

The staging system of remnant gastric cancer (RGC) has not yet been established, with the current staging being based on the guidelines for primary gastric cancer. Often, surgeries for RGC fail to achieve the > 15 lymph nodes needed for TNM staging. Compared with the pN staging system, lymph node ratio (NR) may be more accurate for RGC staging and prognosis prediction. We retrospectively analyzed the data of 208 patients who underwent R0 gastrectomy with curative intent and who have ≤ 15 retrieved lymph nodes (RLNs) for RGC between 2000 and 2014. The patients were divided into four groups on the basis of the NR cutoffs: rN0: 0; rN1: > 0 and ≤ 1/6; rN2: > 1/6 and ≤ 1/2; and rN3: > 1/2. The 5-year overall survival (OS) rates for rN0, rN1, rN2, and rN3 were 84.3%, 64.7%, 31.5%, and 12.7%, respectively. Multivariable analyses revealed that tumor size (p = 0.005), lymphovascular invasion (p = 0.023), and NR (p < 0.001), but not pN stage (p = 0.682), were independent factors for OS. When the RLN count is ≤ 15, the NR is superior to pN as an important and independent prognostic index of RGC, thus predicting the prognosis of RGC patients more accurately.

Entities:  

Year:  2021        PMID: 33479327      PMCID: PMC7820341          DOI: 10.1038/s41598-021-81663-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  22 in total

1.  Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma.

Authors:  Takashi Ichikura; Toshiya Ogawa; Kentaro Chochi; Toshinobu Kawabata; Hidekazu Sugasawa; Hidetaka Mochizuki
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

2.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Okines; M Verheij; W Allum; D Cunningham; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes.

Authors:  Alberto Di Leo; Corrado Pedrazzani; Maria Bencivenga; Arianna Coniglio; Fausto Rosa; Paolo Morgani; Daniele Marrelli; Alberto Marchet; Luca Cozzaglio; Simone Giacopuzzi; Guido Alberto Massimo Tiberio; Giovanni Battista Doglietto; Giovanni Vittimberga; Franco Roviello; Francesco Ricci
Journal:  Ann Surg Oncol       Date:  2014-03-18       Impact factor: 5.344

4.  Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

Authors:  Akira Ema; Keishi Yamashita; Shinich Sakuramoto; Guoqin Wang; Hiroaki Mieno; Masayuki Nemoto; Tomotaka Shibata; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2013-06-26       Impact factor: 7.370

5.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

6.  Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.

Authors:  Dapeng Lin; Yiming Li; Huimian Xu; Junqing Chen; Binbin Wang; Caigang Liu; Ping Lu
Journal:  Am J Clin Oncol       Date:  2013-08       Impact factor: 2.339

7.  The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection.

Authors:  Jing-Yu Deng; Han Liang; Dan Sun; Hong-Jie Zhan; Xiao-Na Wang
Journal:  J Surg Oncol       Date:  2008-10-01       Impact factor: 3.454

8.  [Gastric stump carcinoma: frequency, treatment, complications and prognosis].

Authors:  H Nienhüser; S Blank; L Sisic; R Kunzmann; U Heger; K Ott; M W Büchler; T Schmidt; A Ulrich
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

9.  Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.

Authors:  Hiroaki Saito; Yoji Fukumoto; Tomohiro Osaki; Yoshinori Yamada; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  J Surg Oncol       Date:  2008-02-01       Impact factor: 3.454

10.  Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System.

Authors:  Masatoshi Nakagawa; Yoon Young Choi; Ji Yeong An; Jung Hwa Hong; Jong Won Kim; Hyung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  Ann Surg Oncol       Date:  2016-07-01       Impact factor: 5.344

View more
  3 in total

1.  Surgeon-Pathologist Team Approach Dramatically Affects Lymph Nodes Detection and Improves Patients' Short-Term Outcome.

Authors:  Maria Raffaella Ambrosio; Bruno Perotti; Alda Battini; Caterina Fattorini; Andrea Cavazzana; Rocco Pasqua; Piergaspare Palumbo; Liano Gia; Marco Arganini
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

2.  3D laparoscopic-assisted vs open gastrectomy for carcinoma in the remnant stomach: A retrospective cohort study.

Authors:  Di Wu; Qi-Ying Song; Xiong-Guang Li; Tian-Yu Xie; Yi-Xun Lu; Ben-Long Zhang; Shuo Li; Xin-Xin Wang
Journal:  World J Gastrointest Surg       Date:  2022-08-27

3.  Subtotal versus total gastrectomy for remnant gastric cancer: a systematic review and meta-analysis of observational studies.

Authors:  Ryota Otsuka; Koichi Hayano; Masahiro Yoshida; Hironobu Goto; Yusuke Muneoka; Souya Nunobe; Hisahiro Matsubara
Journal:  Langenbecks Arch Surg       Date:  2021-03-10       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.